Displaying 1101 - 1150 of 4624 results
Released Company Title Industry Topic
11 Jul 2024
07:30 CEST
SpareBank 1 Nordmøre SpareBank 1 Nordmøre: Fremtind Forsikring - resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SpareBank 1 SR-Bank ASA Fremtind Forsikring: Resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SpareBank 1 Østlandet Fremtind Forsikring- Resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SpareBank 1 Gudbrandsdal Fremtind Forsikring - resultat 2. kvartal 2024 og hittil i år - Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SPAREBANK 1 HELGELAND Fremtind Forsikring- Resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SpareBank 1 SMN Fremtind Forsikring - Resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
DRONE VOLT DRONE VOLT annonce le lancement d'une augmentation de capital ouverte à tous avec maintien du droit préférentiel de souscription 50201010 Aerospace Legal
11 Jul 2024
07:30 CEST
SPAREBANK 1 SØRØST-NORGE SOON: Fremtind Forsikring- resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
GENSIGHT BIOLOGICS GenSight Biologics lance une lettre d'information pour les investisseurs particuliers 20103010 Biotechnology Corporate life
11 Jul 2024
07:30 CEST
SpareBank 1 Nord-Norge Fremtind Forsikring - Resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SpareBank 1 SR-Bank ASA Fremtind Forsikring: Result 2nd quarter 2024 and Year-to-Date 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:30 CEST
Boussard Gavaudan BGHL (EUR): NAV(s) 30204000 Closed End Investments Other subject
11 Jul 2024
07:30 CEST
Klaveness Combination Carriers KCC: Second Quarter 2024 Business Update 50206030 Marine Transportation Non-regulatory press releases
11 Jul 2024
07:30 CEST
SPAREBANK 1 HELGELAND Fremtind Forsikring- Result 2nd quarter 2024 and Year-to-Date 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:30 CEST
SpareBank 1 Ringerike Hadeland SpareBank 1 Ringerike Hadeland: Fremtind Forsikring- Resultat 2. kvartal 2024 og hittil i år 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
11 Jul 2024
07:30 CEST
SpareBank 1 SMN Fremtind Forsikring - Result 2nd quarter 2024 and Year-to-Date 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:30 CEST
SpareBank 1 Østlandet Fremtind Forsikring- Result 2nd quarter 2024 and Year-to-Date 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:30 CEST
SPAREBANK 1 SØRØST-NORGE SOON: Fremtind Forsikring- Result 2nd quarter 2024 and Year-to-Date 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:30 CEST
GENSIGHT BIOLOGICS GenSight Biologics Launches Newsletter for Retail Investors 20103010 Biotechnology Corporate life
11 Jul 2024
07:30 CEST
SpareBank 1 Nord-Norge Fremtind Forsikring - Result 2nd quarter 2024 and Year-to-Date 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:15 CEST
EUROFINS SCIENTIFIC Eurofins Provides Update to Key Stakeholders on Current and Upcoming Actions Following Communications Published by Muddy Waters Since 24 June 2024 20102020 Medical Services New
11 Jul 2024
07:01 CEST
BIOPHYTIS Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity 20103010 Biotechnology Other subject
11 Jul 2024
07:01 CEST
BIOPHYTIS Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité 20103010 Biotechnology Other subject
11 Jul 2024
07:00 CEST
VÅR ENERGI ASA Vår Energi: Second quarter and first half 2024 trading update 60101015 Offshore Drilling and Other Services Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:00 CEST
EUROPRIS Transformation programme set to unlock ÖoB potential and boost growth 40401010 Diversified Retailers Half yearly financial reports and audit reports/limited reviews
11 Jul 2024
07:00 CEST
AKASTOR Akastor ASA: Second Quarter and Half Year Results 2024 60101030 Oil Equipment and Services Half yearly financial reports and audit reports/limited reviews
11 Jul 2024
07:00 CEST
AKASTOR Akastor ASA: Resultat for andre kvartal og første halvår 2024 60101030 Oil Equipment and Services Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
11 Jul 2024
07:00 CEST
PUBLIC PROPERTY INVEST ASA Public Property Invest ASA Strong operational performance and financial position 35101010 Real Estate Holding and Development Half yearly financial reports and audit reports/limited reviews
11 Jul 2024
07:00 CEST
Seacrest Petroleo Bermuda Limi Seacrest Petroleo Bermuda Limited: Order from the ANP to upgrade truck loading sites 60101010 Oil: Crude Producers Additional regulated information required to be disclosed under the laws of a Member State
11 Jul 2024
07:00 CEST
KITRON Kitron: Q2 2024 - Robust lønnsomhet og positive utsikter tross sektorutfordringer 50202040 Electronic Equipment: Other Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
11 Jul 2024
07:00 CEST
KITRON Kitron: Q2 2024 - Robust profitability and positive outlook despite sector challenges 50202040 Electronic Equipment: Other Half yearly financial reports and audit reports/limited reviews
11 Jul 2024
07:00 CEST
IPSEN Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential 20103015 Pharmaceuticals -
11 Jul 2024
07:00 CEST
IPSEN Ipsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classe 20103015 Pharmaceuticals -
11 Jul 2024
00:04 CEST
PERSHING SQUARE HOLDING Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 9 July 2024 30204000 Closed End Investments Other subject
10 Jul 2024
21:35 CEST
- Hawk Infinity Software AS completed acquisitions and equity issue - Additional regulated information required to be disclosed under the laws of a Member State
10 Jul 2024
21:20 CEST
SBM OFFSHORE Weekly share repurchase program transaction details 60101030 Oil Equipment and Services Other subject
10 Jul 2024
20:45 CEST
BE Semiconductor Industries N.V. BE Semiconductor Industries N.V. Announces Pricing of €350 Million Bond Offering 10102010 Semiconductors Other subject
10 Jul 2024
20:28 CEST
BlueNord ASA BlueNord: Option Exercise - Issue of New Shares 60101010 Oil: Crude Producers Additional regulated information required to be disclosed under the laws of a Member State
10 Jul 2024
20:27 CEST
SMARTCRAFT ASA SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program 10101015 Software Acquisition or disposal of the issuer’s own shares
10 Jul 2024
20:00 CEST
POUJOULAT POUJOULAT SA : Droits de vote 06/2024 50101025 Building: Climate Control Change in Capital
10 Jul 2024
19:55 CEST
EXPLOSIFS PROD.CHI Droits de vote EPC au 10/07/2024 55201000 Chemicals: Diversified Change in Capital
10 Jul 2024
19:20 CEST
GROUPE LDLC COMPLETION OF THE ACQUISITION OF THE RUE DU COMMERCE BUSINESS 10101020 Consumer Digital Services Alliances and agreements, Mergers, Acquiqitions, Transferts
10 Jul 2024
19:20 CEST
GROUPE LDLC FINALISATION DE L'ACQUISITION DU FONDS DE COMMERCE DE LA SOCIÉTÉ RUE DU COMMERCE 10101020 Consumer Digital Services Alliances and agreements, Mergers, Acquiqitions, Transferts
10 Jul 2024
19:00 CEST
WALLIX Bilan semestriel du contrat de liquidité 10101015 Software Legal
10 Jul 2024
19:00 CEST
WALLIX Information relative au nombre de droits de votes et d'actions au 30 juin 2024 10101015 Software Change in Capital
10 Jul 2024
18:53 CEST
APODACA INVERSIONES INMOBILARIAS SOCIMI S.A. APODACA CORPORATE ACTION DIVIDEND PAYMENT 2023 35102000 Diversified REITs Dividend
10 Jul 2024
18:31 CEST
MULTICONSULT Multiconsult ASA - Status on share buy-back 50101015 Engineering and Contracting Services Acquisition or disposal of the issuer’s own shares
10 Jul 2024
18:30 CEST
UMICORE Umicore - Déclaration de transparence par APG Asset Management 55201020 Specialty Chemicals New
10 Jul 2024
18:30 CEST
UMICORE Umicore - Transparantieverklaring van APG Asset Management 55201020 Specialty Chemicals New
10 Jul 2024
18:30 CEST
UMICORE Umicore - Transparency notification by APG Asset Management 55201020 Specialty Chemicals New